Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 5.08 M10.78 M12.06 M — Research & development ——— — 영업 이익 8.65 M968 K-2.07 M — Non-Operating Income, Total 76.18 M8.99 M-1.59 M — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 76.18 M8.99 M-1.59 M — Unusual income/expense ——— — Pretax income 70.42 M-4.08 M-16.44 M — Equity in earnings —-24 K48 K — Taxes 3 0007 000-34 K — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 70.42 M-4.09 M-16.4 M — Discontinued operations -495 K-965 K-1.35 M — Net income 69.93 M-5.05 M-17.75 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 69.74 M-5.05 M-18.06 M — Basic earnings per share (Basic EPS) 15.05-0.65-10.07 — Diluted earnings per share (Diluted EPS) 15.05-0.65-3.1 — Average basic shares outstanding 4.64 M7.74 M5.73 M — Diluted shares outstanding 4.64 M7.74 M5.73 M — EBITDA 9.04 M2.69 M-1.05 M — EBIT 8.65 M968 K-2.07 M — Cost of revenue -5.57 M12.12 M5.57 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 394 K1.72 M1.02 M —